Auckland, New Zealand, 28 August 2019 - Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held in Auckland today were passed. The seven resolutions were:
Resolution 1: To re-elect Lewis Gradon as a Director.
Resolution 2: To re-elect Donal O’Dwyer as a Director.
Resolution 3: To elect Neville Mitchell as a Director.
Resolution 4: To authorise the Directors to fix the fees and expenses of the Company’s auditor.
Resolution 5: To approve the issue of share rights to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2019.
Resolution 6: To approve the issue of options to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2019.
Resolution 7: To revoke the Company’s current constitution and adopt an updated constitution.
All resolutions were decided by poll. The details of the total number of votes cast in person or by proxy on the polls were as follows:
| Resolution |
Votes For |
% |
Votes Against |
Total Votes Cast |
Abstain |
| Resolution 1 Re-election of Lewis Gradon |
366,211,794 |
99.99 |
34,786 |
366,506,224 |
259,644 |
| Resolution 2: Re-election of Donal O’Dwyer |
362,028,570 |
98.84 |
4,255,366 |
366,506,224 |
222,288 |
| Resolution 3: Election Neville Mitchell |
366,310,274 |
99.99 |
27,823 |
366,506,224 |
168,127 |
| Resolution 4: Authorise Directors to fix fees and expenses of auditor |
366,032,085 |
99.92 |
304,778 |
366,506,224 |
169,361 |
| Resolution 5: Issue of share rights to Lewis Gradon |
340,475,664 |
93.13 |
25,123,366 |
365,902,722 |
303,692 |
| Resolution 6: Issue of options to Lewis Gradon |
338,904,512 |
92.70 |
26,669,393 |
365,902,722 |
328,817 |
| Resolution 7: Revoke constitution and adopt updated constitution |
366,139,655 |
99.98 |
72,793 |
366,506,224 |
293,776 |
Contact: Marcus Driller, VP – Corporate and Company Secretary on +64 9 574 0110. For more information about the company visit our website www.fphcare.com
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Ends
Contact
|
Investors:
Hayden Brown
Investor Relations Manager
[email protected]
+64 (0) 27 807 8073
|
|
|
|
Media:
Karen Knott
Senior Communications Manager
[email protected]
+64 (0) 21 713 911
|
|
|